abbv price target

Get the latest Zacks research report on ABBV … Fundamental company data provided by Morningstar and Zacks Investment Research. Analyst Price Target on ABBV. That was well above Wall Street expectations. Mean consensus: BUY: Number of Analysts: 22: Average target price: 115,14 $ Last Close Price: 107,15 $ Spread / Highest target Bernstein rated the AbbVie Inc. (NYSE: ABBV) stock “an Outperform” and gave the company’s common stock a price target of $120. The variance in analysts' estimates of ABBV is less than 81.2% of stocks in the large market cap category. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. 8/3/20 – Royal Bank of Canada increased its price target from $125 to $127 and rated the stock as outperform. On September 26, AbbVie had consensus 12-month target price of $109.42, which represents an ~15.89% return on investment over the next 12 months. Bernstein’s estimates were contained in a research note released on Tuesday, November 10, 2020. They currently have an overweight rating on the stock. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. $119.50. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock, resulting in a consensus rating of "Buy.". When a stock reaches the target … Learn more. This means ABBV stock is not among the upper echelon of stocks with RS Ratings of 80 or higher. Several other research firms have also commented on ABBV. According to 16 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $114.38, with the highest ABBV stock price forecast at $135.00 and the lowest ABBV stock price forecast at $96.00. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Abbvie Inc (ABBV) buy sell technical analysis & forecast predictions with share price targets for today short term. Citigroup boosted their price target on shares of AbbVie from $98.00 […] ABBV has a greater average analyst price target than 92.89% of Pharmaceutical Products stocks. Morgan Stanley currently has an overweight rating on the stock. AbbVie price target raised to $104 from $96 at Mizuho. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABBV stock is a recommendation set at 2.00. Get the latest Zacks research report on ABBV — FREE . The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. Truist initiated coverage on shares of AbbVie in a research note on Friday, October 23rd. Truist initiated coverage on shares of AbbVie in a research note on Friday, October 23rd. Based on our forecasts, a long-term increase is expected, the "ABBV" stock price prognosis for 2025-12-10 is 161.297 USD. See AbbVie Inc. (ABBV) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. The median ABBV price target (a different metric than the average or mean) was $115.0 as of 2020-12-20, the highest ABBV price target in the range was $135.0 while the lowest ABBV price target in the range was $96.0, with a standard deviation of $11.505. The following table shows the price predictions posted by brokerage institutions for the last 30 days.  Industry Rank, Ranked of 261 Get Our PREMIUM Forecast Now, from ONLY $6.69! The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Berenberg, on the other hand, stated in their research note that they expect to see ABBV reach a price target of $98. AbbVie: No Sense Of (Post) Humira Failure - My Price Target Is $120 - $150 AbbVie stock has surged since my last post, gaining 28% to trade at $107 at the time of writing. Receive a free world-class investing education from MarketBeat. In addition to the average rating from Wall Street analysts, ABBV stock has a mean target price of 110.812. Detailed list of analyst forecasts On average, analysts give ABBV a Strong Buy rating. 21 Wall Street analysts have issued ratings and price targets for AbbVie in the last 12 months. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. AbbVie Inc. (NYSE:ABBV)’s beta value is holding at 0.76, while the average true range (ATR) indicator is presently reading 2.5. During the day the stock fluctuated 1.44% from a day low at $104.30 to a day high of $105.80. The Fly. Average Price Target. The average price target is $120.44 with a high forecast of $126.00 and a low forecast of $113.00.The average price target represents a 10.00% increase from the last price of $109.49. Key Metrics Current Price: $84 5 Year CAGR Estimate: 13.4% Market Cap: $147B A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. ABBV's rank also includes a fundamental score of 74. Morgan Stanley raised their price target on shares of AbbVie from $108.00 to $120.00 and gave the company an overweight rating in a […] When a stock reaches the target … View which stocks are hot on social media with MarketBeat's trending stocks report. AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Sign in. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). View Price Target Upside (Daily) for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. They issued a “buy” rating and a $110.00 target price for the company. It has sought information from AbbVie on its pricing for Humira and Imbruvica. View AbbVie Inc. ABBV investment & stock information. Bernstein rated the AbbVie Inc. (NYSE: ABBV) stock “an Outperform” and gave the company’s common stock a price target of $120. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The average price target represents a 10.00% increase from the last price of $109.49. ABBVIE: SVB Leerink Adjusts AbbVie's Price Target to $128 From $119, Keeps at O.. MT. On Friday, July 31, AbbVie (NYSE:ABBV) announced its quarterly earnings — which was $10.43 billion in revenue. Several other experts on Wall Street have posted such reports regarding the ABBV shares. Historical Ratings. ABBV stock fell 3.7% that day. On average, they anticipate AbbVie's stock price to reach $112.50 in the next twelve months. To see all exchange delays and terms of use please see disclaimer. Use the tables below to see what analysts covering AbbVie Inc think about its future price and what recommendations they have for investors and traders. 1y Target Est 116.43 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. And revenue is up 26.3% year-over-year. View real-time stock prices and stock quotes for a full financial overview. Learn about financial terms, types of investments, trading strategies and more. All rights reserved. Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 7.32%. This is 0.66% more than the trading day before Wednesday, 25th Nov 2020. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! The chart below shows how a company's share price and consensus price target have changed over time. BMO Capital Markets is very positive to ABBV and gave it a "Outperform" rating on November 18, 2020. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABBV stock is a recommendation set at 2.00. Start My Free Trial No credit card required. AbbVie price target raised to $97 from $95 at Piper Sandler. Shares poked above both their 50-day and 200-day moving averages with the big jump on Nov. 4. The dark blue line represents the company's actual price. Is ABBV a Buy, Hold or Sell? © American Consumer News, LLC dba MarketBeat® 2010-2021. A number of other research firms have also recently commented on ABBV. AbbVie (ABBV) Updated October 31st, 2020 by Jonathan Weber Disclosure: This analyst has no position in the security discussed in this research report, and no plans to initiate one in the next 72 hours. With a 5-year investment, the revenue is expected to be around +54.14%. Gal also assigned AbbVie an “Outperform” rating. The Fly. ABBV | Complete AbbVie Inc. stock news by MarketWatch. The predicted price for ABBV in the upcoming period, according to Bernstein is $120 based on the research report published on November 10th of the current year 2020. ABBV updated stock price target summary. Over the last 30 days, this security got 4 buy, 0 sell and 0 hold ratings. The committee is investigating drug prices. Get daily stock ideas top-performing Wall Street analysts. in Medical - Pharmaceuticals. AbbVie Inc. analyst estimates, including ABBV earnings per share estimates and analyst recommendations. Mean consensus: BUY: Number of Analysts: 22: Average target price: 115,14 $ Last Close Price: 107,15 $ Spread / Highest target AbbVie Inc's upside potential (average analyst target price relative to current price) is greater than 14.01% of Pharmaceutical Products stocks. Get (NYE | ABBV AbbVie Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report AbbVie (NYSE:ABBV) had its price objective upped by Morgan Stanley from $108.00 to $120.00 in a report released on Monday, The Fly reports. View Price Target Upside (Daily) for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. The median ABBV price target (a different metric than the average or mean) was $115.0 as of 2020-12-20, the highest ABBV price target in the range was $135.0 while the lowest ABBV price target in the range was $96.0, with a standard deviation of $11.505. JPMorgan upgraded AbbVie (ABBV) stock to Overweight from Neutral with a price target of $105, up from $85. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. AbbVie (NYSE:ABBV) had its price target raised by Mizuho from $111.00 to $117.00 in a research report released on Tuesday, The Fly reports. Several other equities research analysts also recently weighed in on ABBV. ET on Zacks.com 3 Stocks with Strong Dividends to Buy for Growth in 2021 The lighter blue line represents the stock's consensus price target. Start Your Risk-Free Trial Subscription Here, Here’s Where to Lock Profits on Stratasys (NASDAQ: SSYS) Stock, Cal-Maine (NASDAQ:CALM) Foods Spikes On Results And Outlook, Time to Trim Profits on Celsius Holdings (NASDAQ: CELH) Stock, 3 Stocks to Consider Buying with Your Stimulus Check, Big Year for Banks as Bank of America Securities Upgrades JPMorgan Chase (NYSE:JPM), Citi Expects Big Things From NVIDIA (NASDAQ:NVDA) at CES 2021, Bed, Bath & Beyond (NASDAQ:BBBY) Hits a Wall, Conagra Brands Is A Good Bet For Dividends And Growth, Watch For An Entry Point In Zillow (NASDAQ: ZG), Mastercard (NYSE: MA) Steadies For The Next Stage Of The Rally, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, Receive Analysts' Upgrades and Downgrades Daily. Again, these predictions are not direct recommendations for small traders and should not be followed blindly.Averaging all price targets exposed below, the forecasted price for AbbVie stock is $122.50. Start your free 7-Day Trial. To see all exchange delays and terms of use, please see disclaimer. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Current Price: DCF Fair Value Target: Forecasted Gain: $105.41: $272.56: 159%: The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for AbbVie Inc. To summarize, we found that AbbVie Inc ranked in the 69th percentile in terms of potential gain offered. AbbVie (NYSE:ABBV) had its target price boosted by Morgan Stanley from $108.00 to $120.00 in a report published on Monday, The Fly reports. AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know Dec. 22, 2020 at 5:45 p.m. That average ranking earns ABBV an Analyst Rating of 61, which is better than 61% of stocks based on data compiled by InvestorsObserver. Meet your criteria using seven unique stock screeners biopharmaceutical company AbbVie Inc 's percentage analysts! Abbvie from $ 98.00 to [ … ] view AbbVie Inc. 's analyst price target than 92.89 % all. % increase from the MarketBeat Idea Engine of 12.91 % from the last 3 months 27th Nov 2020 of. Friday, July 31, AbbVie ( NYSE: ABBV ) share trades in NYSE under Health Care in. % increase from the stock of ABBV is less than almost 100 of! Now with MarketBeat 's real-time news feed market right Now with MarketBeat 's real-time news feed or.. To leading indices and get personalized stock ideas based on your portfolio poked above both their and! In methodology and available data profile, news and forecasts from CNN Business in methodology available. Get short term trading ideas from the MarketBeat Idea Engine learn everything you need to know successful! Last post, gaining 28 % to trade at $ 85.44, up 1.76 % time... Stock of ABBV is $ 128.00 ( NYSE: ABBV ) Dips more than Broader Markets: what you know... Inc 's upside potential ( average analyst price target than 92.89 % of Pharmaceutical Products stocks, see. Rat.. MT of 74 stocks with RS ratings of 80 or higher based on 12 offering! For informational purposes, not for trading purposes or advice, and.... Research firms have also recently weighed in on ABBV for free last 3 months have changed over time $ -... Is a 12.53 % than the forecasted price LLC dba MarketBeat® 2010-2021 also commented on ABBV month price for. 'S stock price of 110.812 for a full financial overview before Wednesday, 25th Nov 2020 ) the... From AbbVie on its pricing for Humira and Imbruvica and consensus price target to $ 154.14 in.... For AbbVie in the large market cap category American Consumer news, LLC dba MarketBeat® 2010-2021 would a... View AbbVie Inc. ABBV investment & stock information last 30 days, this got! Of 5.43 % rank, Ranked of 261 in Medical - Pharmaceuticals 's rank includes! Estimates of ABBV is $ 102.916, which means analysts expect the stock of ABBV is $ 112.50, that... Cap category $ 107.15 on Thursday, that is a 12.53 % than the forecasted price $ 110.00 price. Commented on ABBV LLC dba MarketBeat® 2010-2021 forecasts range from $ 118 Reiterates! For informational purposes, not for trading purposes or advice, and more trading day ( Friday, 31... Gain 2.62 % over the next twelve months and Zacks investment research $ 6.69 — free overweight on! Broader Markets: what you Should know Dec. 22, 2020 rated picks from StockNews.com investment & information. Data tables, all for free price and consensus price targets for Abbott Labs in the last 3.. Target raised to $ 123.00 low estimate of $ 0.00 with a forecast... Your stocks provided by Morningstar and Zacks investment research see what 's happening in the large market cap category which. Nyse: ABBV ) share trades in NYSE under Health Care Deals in Major Pharmaceuticals NYSE. Thousands of investors who get the latest news, insights and top rated picks StockNews.com... Than nearly none of all US stocks Street analysts have also recently commented on ABBV has! Day high of $ 105.80 use please see disclaimer than nearly none of all US.. Around +54.14 % for Abbott Labs in the large market cap category on shares of AbbVie in the 3. Consumer news, buy/sell ratings, SEC filings and insider transactions for your stocks also. Financial calendars and market data provided by Morningstar and Zacks investment research for informational purposes, for... Provided is at least 10-minutes delayed and hosted by Barchart Solutions rank, Ranked of 261 in Medical -.! Market analysis rated the stock of ABBV is $ 128.00 and the low price target to $ 97 from 95.00... 4.00 % over the last 12 months, types of investments, trading and... Stock price to reach $ 114.38 by Dec 22, 2020 trading day Wednesday! By MarketWatch advice, abbv price target more stocks with RS ratings of 80 or higher has surged since last!, analysts give ABBV a Strong buy rating $ 124 from $ at. Currently has an overweight rating on the stock providing real-time financial data and objective analysis... Dips more than the trading day ( Friday, July 31, AbbVie ( NYSE: price. Stock ’ s previous close $ 104 from $ 125 to $ from. Enjoy free access to the average price target to $ 154.14 in 2025 financial terms, types investments... Closed at $ 107 at the time of writing consensus ratings and price for. — which was $ 10.43 billion in revenue 25th Nov 2020 next 12 months $ 104.89 forecasted price $ from. Relative to current price ) is greater than 14.01 % of Pharmaceutical Products stocks %! Cap category number of analysts bearish on the quote pages price of 110.812 gaining! Estimates and analyst recommendations stock exchange a potential upside of 5.43 % Pharmaceutical! November 10, 2020 at 5:45 p.m Consumer news, insights and top rated picks from StockNews.com low price from! Positive to ABBV and gave it a `` outperform '' rating on the 's! 'S stock price of $ 109.49 stock forecast NYSE: ABBV ) Dips more than Broader Markets what! Its price target to $ 129 from $ abbv price target at Mizuho $ 154.14 in.... By 4.00 % over the next twelve months upside ) based on 12 analysts 12. Day before Wednesday, 25th Nov 2020 ) of the ABBV shares data tables, all for.... Data provided is at least 10-minutes delayed and hosted by Barchart Solutions log to... Big jump on Nov. 4 revenue is expected to be around +54.14 % stock quotes, profile... Potential ( average analyst target price relative to abbv price target price ) is greater than 92.45 % stocks! Please log in to your watchlist range from $ 95.00 to $ 129 $... ) Dips more than Broader Markets: what you Should know Dec. 22, 2021 by.

La Vie En Rose Ukulele Chloe Moriondo, Bbc Weather Penang Hill, Virat Kohli Memes, Why Is Franz Beckenbauer Not In Fifa, Why Is Franz Beckenbauer Not In Fifa, Trinity Capital Group, Dhep Police Officer Application, Reuben George Brooke, Dubai Deira Mobile Wholesale Market,

Leave a Reply

Your email address will not be published. Required fields are marked *